Indian Phosphate share price made a stellar stock market debut on Tuesday led by heavy demand for its shares in the initial public offering (IPO). Indian Phosphate shares were listed at ₹188.10 ...

So the recent news that a new bone-strengthening drug called abaloparatide will soon be available on the NHS was music to my ears. Particularly as I have just learnt, following a DEXA bone-density ...

Indian Phosphate IPO: The initial public offering (IPO) of Indian Phosphate Ltd has been opened for public subscription on Monday, August 26. The price band of the SME IPO was fixed at Rs 94-99 per ...

Monday's appointments follow the sudden exits of leading figures, many after accusations of wrongdoing as the Communist-run country stepped up its anti-graft drive over the last two years ...

Indian Phosphate IPO: The initial public offering (IPO) of Indian Phosphate began on Monday, August 26 and concluded on Thursday, August 29.(https://indianphosphate ...

Still, the feasibility of ovarian tissue cryopreservation (OTC) following graft failure (GF) of HSCT remains unknown. In this study, we report the first case of OTC following a GF of allogenic HSCT ...